The $43 billion merger was announced earlier this year. To complete the merger, Medtronic was required to sell Covidien’s catheter business, which Spectranetics purchased for $30 million earlier this month.
The approval was won on a five-zero vote in the FTC, and Canadian officials also approved the deal today. There will be a monitor supervising the catheter business’s transfer to Spectranetics.
Medtronic is still on target to complete the acquisition in early 2015, according to the report.
More articles on orthopedic devices:
Orthofix financial report saga: Deadlines extended to January 2015, trading continues
Alphatec Spine to attend 2 investor conferences in December
Is Stryker’s move for Smith & Nephew imminent? 10 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
